Company Filing History:
1 out of 1,217 
1 out of 3,540 
Years Active: 2000-2002
Title: John O Ojeifo: Innovator in Leukemia Treatment
Introduction
John O Ojeifo is a notable inventor based in Washington, DC, who has made significant contributions to the field of cancer treatment, particularly leukemia. With a focus on enhancing the immune response against leukemia cells, Ojeifo has been awarded 2 patents for his innovative methods.
Latest Patents
Ojeifo's latest patents include a method for increasing the antigen presenting ability of leukemia cells. This invention relates to techniques that enhance the intracellular calcium levels in these cells, thereby improving their ability to present antigens. Additionally, he has developed a method for inducing monocytes to exhibit the phenotype of activated cells. This invention also involves increasing intracellular calcium levels and includes methods for obtaining monocytes, as well as inducing bone marrow progenitor cells and endothelial cells to express immune response-related molecules.
Career Highlights
Throughout his career, Ojeifo has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Department of Health and Human Services. His work has focused on advancing the understanding and treatment of leukemia through innovative methodologies.
Collaborations
Ojeifo has collaborated with notable colleagues such as Peter A Cohen and Brian J Czerniecki, contributing to the advancement of research in his field.
Conclusion
John O Ojeifo's contributions to leukemia treatment through his patented methods highlight his dedication to improving cancer therapies. His innovative approaches have the potential to significantly impact the field of immunology and cancer treatment.